FFA
ANIK icon

Farther Finance Advisors’s Anika Therapeutics ANIK Stock Holding History

Farther Finance Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.11K Sell
209
-4
-2% -$77 ﹤0.01% 5122
2026
Q2 		$3.16K Buy
213
+107
+101% +$1.59K ﹤0.01% 5003
2026
Q1 		$1.59K Buy
106
+25
+31% +$290 ﹤0.01% 4973
2025
Q4 		$778 Sell
81
-40
-33% -$383 ﹤0.01% 4964
2025
Q3 		$1.14K Sell
121
-1,655
-93% -$15.8K ﹤0.01% 4332
2025
Q2 		$18.8K Buy
1,776
+1,775
+177,500% +$22.4K ﹤0.01% 2717
2025
Q1 		$15 Sell
1
-6
-86% -$100 ﹤0.01% 4205
2024
Q4 		$115 Sell
7
-45
-87% -$888 ﹤0.01% 3762
2024
Q3 		$1.28K Sell
52
-25
-32% -$648 ﹤0.01% 3160
2024
Q2 		$1.99K Buy
77
+40
+108% +$1.04K ﹤0.01% 2799
2024
Q1 		$951 Hold
37
– – ﹤0.01% 2800
2023
Q4 		$838 Buy
+37
New +$766 ﹤0.01% 2799

Other funds holding ANIK

B
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Farther Finance Advisors's ANIK Position: Q3 2026 in Review

Farther Finance Advisors reduced its Anika Therapeutics (ANIK) stake by 1.9% in Q3 2026, selling an estimated $77 and leaving 209 shares worth $4.11K. The position accounts for ﹤0.01% of the portfolio, ranked #5122.

Farther Finance Advisors first reported a position in ANIK in Q4 2023 and has held it in 12 quarters since. The position peaked at $18.8K in Q2 2025. 9 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.

  • Farther Finance Advisors held 209 shares of Anika Therapeutics worth $4.11K as of Q3 2026.
  • Farther Finance Advisors sold 4 Anika Therapeutics shares in Q3 2026, an estimated $77.
  • Anika Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5122 holding.
  • Farther Finance Advisors first reported a position in Anika Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Anika Therapeutics position peaked at $18.8K in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.